ArticleFrontiers in medicine2026
Case Report: Atypical ocular surface squamous cell carcinoma.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ocular surface squamous neoplasia (OSSN) is the most common ocular surface neoplasm. Ocular surface squamous cell carcinoma (OS-SCC) represents the invasive malignant component within the spectrum of OSSN. The patient in this case report presented with manifestations resembling herpes simplex keratitis at the initial visit, without the typical clinical features of OS-SCC. The diagnosis was revised after close follow-up, and the patient achieved improvement with anti-metabolite therapy. At the time of recurrence, the clinical manifestations were similar to scleral abscess, still without the typical features of OS-SCC. A definitive diagnosis was finally confirmed by surgery following close follow-up. This patient lacked typical clinical manifestations of OS-SCC in both episodes of onset. The diagnosis was revised based on close follow-up and a pathological biopsy, and the treatment regimen was adjusted in a timely manner, resulting in a favorable final prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.